Clinical Trial Update: IRon Nanoparticle Enhanced MRI in the Assessment of Myocardial infarctioN [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating iron nanoparticle-enhanced MRI for assessing myocardial infarction, with the study status reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammation
• Myocardial Infarction

Snippet

Sponsor: University of Edinburgh | Conditions: Myocardial Infarction, Inflammation | Phase 2 | Status: COMPLETED